Ahtaan esinahan (fimoosin) hoito 0.1 % mometasonifuroaattivoiteella yli 6-v pojilla

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-010164-42-FI

Enrollment

Registered

2009-02-04

Start date

2009-04-29

Completion date

Unknown

Last updated

2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tutkimuspotilaat yli 6-v poikia, jotka tulevat lääkärin lähetteellä hoitoon ahtaan esinahan vuoksi MedDRA version: 9.1 Level: LLT Classification code 10034878 Term: Phimosis

Interventions

Trade Name: Elocon 0.1% emulsiovoide Pharmaceutical Form: Cutaneous emulsion INN or Proposed INN: mometasone furoate Pharmaceutical form of the placebo: Cutaneous emulsion Route of administration of t

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026